Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

Moxifloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for moxifloxacin hydrochloride and what is the scope of freedom to operate?

Moxifloxacin hydrochloride
is the generic ingredient in five branded drugs marketed by Watson Labs Inc, Novartis Pharms Corp, Aurobindo Pharma Ltd, Mylan Pharms Inc, Teva Pharms Usa, Dr Reddys Labs Ltd, Crossmedika Sa, Torrent Pharms Ltd, Lupin Ltd, Fresenius Kabi Usa, Bayer Hlthcare, and Novel Labs Inc, and is included in fifteen NDAs. There are eight patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Moxifloxacin hydrochloride has one hundred and sixty-one patent family members in forty-seven countries.

There are eighteen drug master file entries for moxifloxacin hydrochloride. Twenty-three suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: moxifloxacin hydrochloride

Tradenames:5
Patents:8
Applicants:12
NDAs:15
Drug Master File Entries: see list18
Suppliers / Packagers: see list23
Bulk Api Vendors: see list58
Clinical Trials: see list1,070
Patent Applications: see list1,067
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:moxifloxacin hydrochloride at DailyMed

Pharmacology for Ingredient: moxifloxacin hydrochloride

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

Tentative approvals for MOXIFLOXACIN HYDROCHLORIDE

Applicant Application No. Form Dosage
► Subscribe► SubscribeSOLUTION; OPHTHALMIC0.5%
► Subscribe► SubscribeSOLUTION; OPHTHALMIC0.5%
► Subscribe► SubscribeTABLET;ORAL400MG
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare
AVELOX
moxifloxacin hydrochloride
TABLET;ORAL021085-001Dec 10, 1999ABRXYesYes► Subscribe► Subscribe
Crossmedika Sa
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin hydrochloride
TABLET;ORAL205348-001Jan 14, 2016ABRXNoNo► Subscribe► Subscribe
Bayer Hlthcare
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
moxifloxacin hydrochloride
SOLUTION;IV (INFUSION)021277-001Nov 30, 2001RXYesYes5,849,752► Subscribe ► Subscribe
Teva Pharms Usa
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin hydrochloride
TABLET;ORAL077437-001Feb 18, 2014ABRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin hydrochloride
SOLUTION;IV (INFUSION)205572-001Apr 3, 2015RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot